Abe K, Miyazawa Y, Nakazawa S, Onose M, et al. Real-World Outcomes of Radium-223 Therapy in Metastatic Castration-Resistant
Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide
Continuation. Int J Urol 2026;33:e70591.
PMID: 42544862
|